mrt-8102
·Code: MRT-8102
mrt-8102: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | Phase 1 |
Clinical Trials (1)
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRT-8102 in Healthy Participants and in Participants at Cardiovascular Risk With Elevated CRP
Frequently asked questions
Who is developing mrt-8102?
mrt-8102 is being developed by Monte Rosa Therapeutics, Inc..
How many clinical trials involve mrt-8102?
BioSniper tracks 1 clinical trial involving mrt-8102.
Get deeper analysis on mrt-8102
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis